SER Serina: Earnings per share for the trailing year

Serina Therapeutics Inc (SER) - corporate logo

Serina Therapeutics, Inc. (SER) is implementing automated data analysis systems and robotic screening to accelerate drug development. However, global instability is hindering international cooperation and patent protection, creating risks for component supplies. This EPS value chart on GURU.Markets, which stands at 70.10, complements the outlook for a business developing an innovative POZ system for Parkinson's disease therapy and partnerships with industry behemoths.

serinatherapeutics.com (SER): Earnings per share for the last twelve months from 11/23/2025 to 11/18/2026

Serina Pharma - analytical breakdowns and key metrics (SER)

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental valuation:SER, Serina Therapeutics Inc
Core merchandise of Serina

This indicator measures the continuous dynamics of earnings per share over twelve months, allowing for an assessment of business scaling rates without quarterly distortions. By analyzing the annual growth rate of net income per share (ttm), an investor compares the speed of capital growth with the efficiency of the polymer drug delivery platform, which is skillfully coordinated by the stable management team of Serina Therapeutics, Inc. (SER).

Competitor analysis

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|Earnings per share for the last twelve months BTAI (BioXcel Therapeutics)|Earnings per share for the last twelve months ProMIS Neurosciences, Inc. PMN|APUS (Apimeds) - Earnings per one share for the last 12 months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)